<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00910819</url>
  </required_header>
  <id_info>
    <org_study_id>IOM TKK</org_study_id>
    <nct_id>NCT00910819</nct_id>
  </id_info>
  <brief_title>Tumour Registry Colorectal Cancer</brief_title>
  <acronym>TKK</acronym>
  <official_title>Prospective and Retrospective Observation of the Adjuvant and Palliative Treatment Strategies in the Therapy of Colorectal Cancer in Germany</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>iOMEDICO AG</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Arbeitskreis Klinische Studien</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Arbeitsgemeinschaft fur Internistische Onkologie</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>iOMEDICO AG</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To describe treatment reality of patients with colorectal cancer treated by office-based and
      clinic-based medical oncologists in Germany.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The TKK is a prospective, longitudinal, nation wide cohort study with the purpose to record
      information on the antineoplastic treatment of colorectal cancer in Germany. The registry
      will follow patients for up to five years. It will identify common therapeutic sequences and
      changes in the treatment of the disease. At inclusion, data in patient characteristics,
      comorbidities, tumor characteristics, biomarker testing and previous treatments are
      collected. During the course of observation data on all systemic treatments, radiotherapies,
      surgeries, and outcome are documented.

      The impact of nutrition (CoNut) and physical activity (CoNut) on the course of the adjuvant
      disease will be examined, as well as long-term effects of adjuvant treatment (CoTox) and the
      final phase of the palliative process (CoLife). Based on the available data a prognostic
      score will be developed.
    </textblock>
  </detailed_description>
  <overall_status>Active, not recruiting</overall_status>
  <start_date>September 2006</start_date>
  <completion_date type="Anticipated">March 2020</completion_date>
  <primary_completion_date type="Anticipated">March 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Course of Antineoplastic Treatment</measure>
    <time_frame>5 years</time_frame>
  </primary_outcome>
  <enrollment type="Actual">6500</enrollment>
  <condition>Colorectal Cancer</condition>
  <eligibility>
    <study_pop>
      <textblock>
        Colorectal cancer patients undergoing antineoplastic treatment.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Colorectal cancer

          -  18 years and older

          -  Antineoplastic treatment

        Exclusion Criteria:

          -  No colorectal cancer

          -  Below 18 years

          -  No antineoplastic treatment
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Roland Schnell, MD</last_name>
    <role>Study Chair</role>
  </overall_official>
  <location>
    <facility>
      <name>iOMEDICO AG</name>
      <address>
        <city>Freiburg</city>
        <state>BW</state>
        <zip>79108</zip>
        <country>Germany</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <results_reference>
    <citation>Marschner N, Arnold D, Engel E, Hutzschenreuter U, Rauh J, Freier W, Hartmann H, Frank M, JÃ¤nicke M. Oxaliplatin-based first-line chemotherapy is associated with improved overall survival compared to first-line treatment with irinotecan-based chemotherapy in patients with metastatic colorectal cancer - Results from a prospective cohort study. Clin Epidemiol. 2015 Apr 20;7:295-303. doi: 10.2147/CLEP.S73857. eCollection 2015.</citation>
    <PMID>25945067</PMID>
  </results_reference>
  <verification_date>August 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 28, 2009</study_first_submitted>
  <study_first_submitted_qc>May 29, 2009</study_first_submitted_qc>
  <study_first_posted type="Estimate">June 1, 2009</study_first_posted>
  <last_update_submitted>August 18, 2017</last_update_submitted>
  <last_update_submitted_qc>August 18, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">August 22, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Colorectal Cancer</keyword>
  <keyword>Advanced Colorectal Cancer</keyword>
  <keyword>Epidemiology</keyword>
  <keyword>Health Services Research</keyword>
  <keyword>Germany</keyword>
  <keyword>Registry</keyword>
  <keyword>Palliative Care</keyword>
  <keyword>Palliative Treatment</keyword>
  <keyword>Adjuvant Drug Therapy</keyword>
  <keyword>Nutrition Assessment</keyword>
  <keyword>Physical Activity</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colorectal Neoplasms</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

